eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hepatitis c |
| Symptom | |infection |
| Sentences | 461 |
| PubMedID- 20300411 | The association between h. pylori infection and cirrhosis in patients with hepatitis c virus has been documented in different parts of the world; nevertheless, no conclusive data is available in egypt. |
| PubMedID- 23874742 | infection with hepatitis c virus (hcv) is etiologically involved in liver cirrhosis, hepatocellular carcinoma and b-cell lymphomas. |
| PubMedID- 24580042 | The management of co-infection with hiv and hepatitis c virus (hcv) is complicated by viral and drug-drug interactions, treatment-related side effects, and the poor response to therapy of certain hcv genotypes. |
| PubMedID- 20108989 | Chronic infection with hepatitis c virus (hcv) is a major healthcare problem, affecting an estimated 170 million people worldwide. |
| PubMedID- 21637766 | Chronic infection with hepatitis c virus (hcv) has been estimated to affect 3.2 million persons in the united states and 130 million worldwide and is a leading cause of liver failure and the need for liver transplant . |
| PubMedID- 22187946 | Chronic infection with hepatitis c virus (hcv), mainly genotype 1, has been shown to be associated with insulin resistance and type 2 diabetes. |
| PubMedID- 21784304 | This study aimed to estimate human immunodeficiency virus (hiv) co-infection with hepatitis c and b viruses (hcv and hbv) and their risk factors in a rural area of shanxi province with a history of commercial blood donation. |
| PubMedID- 25888935 | Chronic infection with hepatitis c virus (hcv) affects approximately 170 million people worldwide, and it is associated with increased morbidity and mortality secondary to cirrhosis and hepatocarcinoma (hcc) 1. |
| PubMedID- 22911841 | Several factors have been identified as contributing to the excess risk of mortality observed in idus in the cart era including decreased access and adherence to cart , , and more comorbidities such as co-infection with hepatitis c , . |
| PubMedID- 23528526 | It has been suggested that infection with hepatitis c virus may inhibit hepatitis b virus replication. |
| PubMedID- 21970718 | infection with hepatitis c virus (hcv) represents the major cause of liver disease, affecting more than 170 million individuals worldwide. |
| PubMedID- 26405760 | infection with the hepatitis c virus (hcv) is believed to affect about 2% of the world population and represents the major cause of chronic liver disease, liver cirrhosis and hepatocellular carcinoma 1. |
| PubMedID- 23481134 | infection with the hepatitis c virus (hcv) can result in both acute and chronic hepatitis. |
| PubMedID- 20886072 | For infection with hepatitis c virus, the cultured jfh-1 strain was used. |
| PubMedID- 26481253 | Purpose: with daas still only being licensed for chronic hcv infection, the ongoing epidemic of acute hepatitis c (ahc) infection among msm highlights the need to identify factors allowing for optimal hcv treatment outcome. |
| PubMedID- 22836592 | Depressive symptoms, other substance use (crack/cocaine, marijuana, and tobacco), co-infection with hepatitis c virus (hcv), and heavy drinking prior to enrollment were associated with trajectories involving future heavy drinking. |
| PubMedID- 24713004 | Chronic infection with hepatitis c virus (hcv) is a leading indicator for liver disease. |
| PubMedID- 24168254 | From 2002 to 2011, the standard of care treatment for chronic infection with hepatitis c virus (hcv) was 24 or 48 weeks of therapy with pegylated interferon-alfa (peg-ifn) and ribavirin (rbv). |
| PubMedID- 19950239 | Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. |
| PubMedID- 25535325 | infection with hepatitis c virus (hcv) is characterized by systemic oxidative stress that is caused by either viral core protein or chronic inflammation. |
| PubMedID- 24621321 | Chronic infection with hepatitis c virus (hcv) affects up to 170 million individuals worldwide 1 and may lead to progressive hepatic fibrosis and cirrhosis, with risk of liver failure and hepatocellular carcinoma. |
| PubMedID- 20557368 | Objectives: to elucidate the efficacy of interferon (ifn)-beta induction therapy followed by pegylated ifn alpha and ribavirin for chronic infection with hepatitis c virus (hcv). |
| PubMedID- 24454973 | Htlv-1 infection reduces clearance rates of hepatitis c virus and increases the risk of liver disease and liver disease-related deaths . |
| PubMedID- 20062526 | Persistent infection with hepatitis c virus (hcv), a single-stranded positive rna virus of the flaviviridae family, is a major cause of liver disease and a global public health problem. |
| PubMedID- 23151512 | Chronic infection with hepatitis c virus (hcv) is an important cause of end stage liver disease worldwide. |
| PubMedID- 24342744 | Exclusion criteria included infection with hepatitis c or d viruses or human immunodeficiency virus. |
| PubMedID- 21867939 | infection with the hepatitis c virus (hcv) is a major cause of chronic liver disease and a leading indication of liver transplantations worldwide. |
| PubMedID- 24008390 | The leading cause of hepatic fibrosis and cirrhosis is infection with hepatitis c virus (hcv), and of the patients with hcv-induced cirrhosis, 2% to 5% develop hepatocellular carcinoma (hcc), with a survival rate of 7%. |
| PubMedID- 26378794 | It is possible that some participants in some studies were not excluded, due to co-infection with hepatitis c virus, as observed in the study of perez et al . |
| PubMedID- 24416131 | infection with hepatitis c virus (hcv) is one of the major risk factors for the development of hcc 2. |
| PubMedID- 21187906 | Chronic infection with the hepatitis c virus (hcv) is amongst the most frequent causes of liver cirrhosis and hepatocellular carcinoma 1. |
| PubMedID- 26271205 | It remains unclear how co-infection with hepatitis c virus impacts on the trajectory of kidney disease among hiv-infected patients. |
| PubMedID- 23933401 | Background and aims: infection with the hepatitis c virus (hvc) is one of the most common viral infections worldwide. |
| PubMedID- 25314116 | Historically, clinical trials of regimens to treat chronic infection with hepatitis c virus (hcv) have used, as their primary efficacy endpoint, a sustained virological response (svr)-defined as hcv rna levels below a designated threshold of quantification-24 weeks after the end of treatment (svr24). |
| PubMedID- 20875187 | Other independent risk factors were infection with hepatitis c (or 19.6, 95% ci 2.4, 164), age over 60 years (or 18.5, 95% ci 2.3, 151) and multi-drug-resistant tb (or 8.2, 95% ci 1.3, 53.6). |
| PubMedID- 24008295 | Persistent infection with hepatitis c virus (hcv) is a major risk toward development of hepatocellular carcinoma (hcc). |
| PubMedID- 20862263 | C) time course of cb1 expression following de novo infection with jfh-1 hepatitis c virus. |
| PubMedID- 20846420 | No patient had co-infection with hepatitis c virus, hepatitis d virus, or human immunodeficiency virus. |
| PubMedID- 23626783 | Differential expression of candidate virus receptors in human t lymphocytes prone or resistant to infection with patient-derived hepatitis c virus. |
| PubMedID- 20332260 | Background: chronic infection with hepatitis c virus (hcv) confers increased risk for chronic renal disease, and numerous reports suggest an association with renal cell carcinoma (rcc), a cancer with rapidly rising global incidence. |
| PubMedID- 24307460 | Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis c virus. |
| PubMedID- 22899946 | Chronic infection with hepatitis c virus (hcv) is associated with a wide spectrum of extrahepatic manifestations, affecting different organ systems. |
| PubMedID- 21716792 | It is worth noting that in patients presenting with anogenital wart, other associated stis were hiv, syphilis, hsv-2, hepatitis b, and hepatitis c. in patients with hpv–hiv co-infection, the warts were multiple, diffuse, and larger in size. |
| PubMedID- 22911697 | in addition to traditional ckd risk factors such as diabetes and hypertension, co-infection with hepatitis c virus (hcv) has been suggested as a possible risk factor for ckd in hiv-positive individuals. |
| PubMedID- 23740063 | Introduction: autoantibodies are often produced during infection with chronic hepatitis c virus (hcv), but it remains controversial whether they influence the biochemical profile and histological features of this disease. |
| PubMedID- 25384189 | Direct-acting antivirals (daas) have significantly improved the treatment of infection with the hepatitis c virus. |
| PubMedID- 25443346 | There has long been evidence that hepatitis c can lead to persistent infection in a high proportion of infected individuals, and can progress to chronic liver disease, cirrhosis and hepatocellular carcinoma (hcc). |
| PubMedID- 24824502 | Finally, ampk may be involved in viral infection: downregulation of ampk during hepatitis c virus infection appears to be essential for efficient viral replication. |
| PubMedID- 22412904 | Additional modifying factors including gender, alcohol consumption or co-infection with hepatitis c virus are involved , . |
| PubMedID- 22205621 | infection with hepatitis c virus (hcv) affects approximately 170 million people worldwide. |